Clinical trial
Randomized Trial of Rosuvastatin for Acutely Injured Lungs From Sepsis
NCT00979121 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Rosuvastatin for Acutely Injured Lungs From Sepsis
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2010
- Completion date
- November 30, 2013
- Enrollment
- 745 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.